Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS)

NCT02731560 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
74
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Prof. Abid Z. Farooqi

Collaborators